Literature DB >> 528164

Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension.

T Owman, A Lunderquist, A Alwmark, B Borjesson.   

Abstract

Splenectomy in cases of hypersplenism involves significant risk of serious complications, including infection, hemorrhage, portal systemic thrombosis, and necrosis of the stomach or small bowel. Alternative procedures such as transcatheter embolization have been associated with a high frequency of splenic or subphrenic abscess, preventing clinical use. We used partial splenic embolization under careful antibiotic protection to successfully treat thrombocytopenia in 18 patients, most of whom had hypersplenism and splenomegaly secondary to portal hypertension. Of the 30 embolizations performed, the only serious complications encountered were abscess in two patients (who had almost total infarction) and four cases of splenic vein thrombosis. We investigated the possible effect of splenic embolization on portal venous pressure in three patients and found no pressure change.

Entities:  

Mesh:

Year:  1979        PMID: 528164     DOI: 10.1097/00004424-197911000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  13 in total

1.  Idiopathic portal hypertension in renal transplant recipients: report of two cases.

Authors:  N Yoshimura; T Oka; Y Ohmori; T Yasumura; H Kohnosu; T Kobashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  Evaluation of splenic embolization in patients with portal hypertension and hypersplenism.

Authors:  A Alwmark; S Bengmark; P Gullstrand; B Joelsson; A Lunderquist; T Owman
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

3.  Partial splenic embolization for painful splenomegaly.

Authors:  C J Grassi; L M Boxt; M A Bettmann
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

4.  Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.

Authors:  Yanyan Wu; Hongyu Li; Tiansong Zhang; Zhaohui Bai; Xiangbo Xu; Giovanni Battista Levi Sandri; Le Wang; Xingshun Qi
Journal:  Adv Ther       Date:  2021-03-09       Impact factor: 3.845

5.  Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging.

Authors:  Jun Koizumi; Chihiro Itou; Rick Wray; Kazunori Myojin; Takeshi Hashimoto; Yoshimi Nagata; Hiroshi Yamamuro; Tomoatsu Tsuji; Tamaki Ichikawa; Kouichi Shiraishi; Tatehiro Kagawa; Tetsuya Mine; Norihito Watanabe; Mitsunori Matsumae; Bertrand Janne d'Othée
Journal:  Eur Radiol       Date:  2012-11-19       Impact factor: 5.315

6.  Portal hypertensive gastropathy with portal thrombosis successfully treated with partial splenic embolization.

Authors:  Hisamitsu Miyaaki; Tatsuki Ichikawa; Kazuhiko Nakao; Shigeyuki Takeshita; Hidetaka Shibata; Eisuke Ozawa; Motohisa Akiyama; Satoshi Miuma; Masumi Fujimoto; Katsumi Eguchi
Journal:  Clin J Gastroenterol       Date:  2009-03-19

7.  Splenic embolization.

Authors:  D G Spigos; W S Tan; M F Mozes; K Pringle; I Iossifides
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

8.  Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.

Authors:  Jin-Hua Huang; Fei Gao; Yang-Kui Gu; Wen-Quan Li; Lian-Wei Lu
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 9.  Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis.

Authors:  Sharon M Weber; Layton F Rikkers
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

10.  Guidelines on the use of gelatin sponge particles in embolotherapy.

Authors:  Shiro Miyayama; Koichiro Yamakado; Hiroshi Anai; Daisuke Abo; Tetsuya Minami; Haruyuki Takaki; Taishi Kodama; Takashi Yamanaka; Hideyuki Nishiofuku; Kengo Morimoto; Takeshi Soyama; Yu Hasegawa; Koichi Nakamura; Tomoaki Yamanishi; Morio Sato; Yasuo Nakajima
Journal:  Jpn J Radiol       Date:  2014-02-08       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.